Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
| Product Code | KAL00179 |
| Publication Date | September 2009 |
| Publisher | Kalorama Information |
| Product Type | Report |
| Pages | 110 |
| ISBN Number | not applicable |
Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems
With pharmaceutical companies increasingly looking for ways to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the industry. Kalorama's Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems provides detail for business planners on the market for implantable / injectable delivery system markets.
Biopharmaceutical products are driving growth of needle-free systems; there will likely be significant increases in revenues in the vaccine arena. This report looks at that trend and reports current and forecasted revenues for the implantable/injectable drug delivery market, segmented into two main categories:
Needle-free drug delivery
Other Injectable/Implantable
Kalorama's unique analysis offers segmentation of this market for:
Drug Delivery Techology Revenues
Pharmaceuticals Sold via Delivery Technology
This breakout makes the report relevant to business plans of either device technology companies or pharmaceutical concerns. (This market analysis does not include drug-eluding stents or prefilled or regular syringes. Kalorama considers these seperate markets)
With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, drug delivery has become an important focus of the pharmaceutical industry.
Kalorama's Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems, the second volume of Kalorama's popular series focusing on global drug delivery systems markets, provides the definitive break down of the market for implantable / injectable delivery system markets. The report covers both pharmaceuticals sold through implantable/injectable delivery systems and the technologies themselves including:
This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:
Detailed Profiles of Key Companies in Implantable/Injectable Delivery and Brief Round-Up of smaller players
Current Market Size and Forecasts to 2013
Needle-Free Cost Savings, Protein-Coated Microcrystal Technology, Nanotechnology, and Other Trends and Developments
New Products in Development
Kalorama's trusted information-gathering process provides most accurate study of the implantable/injectable delivery drug market available today. Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.
Companies Profiled in the report include:
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- pSivida
- SurModics, Inc
- Zogenix Corporation
- AP Pharma
- Baxter BioPharma Solutions
- QLT USA, Inc
- Ypsomed Holding AG
Kalorama has also published Drug Delivery Markets: Oral Delivery, which details markets for oral technology enhancements which have increased drug product sales and extended patent life.
Contents
- Chapter One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Implantable/Injectable Drug Delivery Marke
- The Implantable/Injectable Drug Delivery Only Market
- Competitor and Market Analysis
- Chapter Two: Introduction
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Auto-Injectors
- Pen Injectors
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Products
- Targeted Injection Drug Delivery
- Products
- Lipsome
- Niosome
- Microspheres and Nanoparticles
- Cyclodetrins
- Prodrug
- Polymeric Micelles
- Pegylation
- Chapter Three: Trends and Developments
- Drivers of The Implantable/Injectable Drug Delivery Market
- Biologics
- Cancer
- Pen Injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- Microchip Technology
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
- Chapter Four: Market Size and Growth
- The Total Implantable/Injectable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
- Chapter Five: Competitive and Market Analysis
- Competitive Landscape
- Market Analysis
- Chapter Six: Company Profiles
- Alkermes, Inc.
- Alza Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- Cydex, Inc.
- Mgi Pharma, Inc
- Nektar Therapeutics
- Pacira Pharmaceuticals, Inc.
- Psivida
- Surmodics, Inc
- Zogenix Corporation
- Companies in Brief
- Ap Pharma
- Baxter Biopharma Solutions
- Qlt USA, Inc
- Ypsomed Holding Ag
- Appendix: Company Directory
- List of Tables
- Table of Exhibits
- Chapter One: Executive Summary
- List of Figures
- Figure 1-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-201
- Chapter Two: Introduction
- List of Tables
- Table 2-1 Sequence of Drug Action
- Table 2-2 Marketed Products Using Liposomal Drug Delivery
- Table 2-3 Marketed Products Using Nanoparticle Drug Delivery
- Chapter Three: Trends and Developments
- List of Tables
- Table 3-1 Select Products in Development by Drug Delivery Companies
- Chapter Four: Market Size and Growth
- List of Tables
- Table 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013
- List of Figures
- Figure 4-1 The Worldwide Market for Implantable/Injectable Drug Delivery Technology and Pharmaceuticals 2003-2013
- List of Tables
- Table 4-2 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013
- List of Figures
- Figure 4-2 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery by Type 2003-2013
- List of Tables
- Table 4-3 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2003-2013
- List of Figures
- Figure 4-3 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2008
- Figure 4-4 The Worldwide Market for Pharmaceuticals Utilizing Injectable/Implantable Drug Delivery Market Share by Type 2013
- List of Tables
- Table 4-4 The Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2003-2013
- Table 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2003-2013
- List of Figures
- Figure 4-5 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2008
- Figure 4-6 The Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2013
- Chapter Five: Competitive and Market Analysis
- List of Tables
- Table 5-1 Leading Suppliers of Implantable/Injectable Drug Delivery Technology
- List of Figures
- Figure 5-1 Cost per Million Injections by Injector Type